CiRC Biosciences

United States
Victoria, Virginia, United States

Company profile

CiRC Biosciences company profile

CiRC Biosciences operates in the biotechnology industry, focusing on the development of potential cell therapy treatments. The company is currently in the pre-clinical development stage for a treatment for retinitis pigmentosa (RP) and dry age-related macular degeneration. These conditions are related to vision loss, and CiRC Biosciences is working on innovative solutions to address them. The company is a portfolio company of Paragon Biosciences.

Business identity

Contact email
[email protected]
Phone number
1 312 -847-1360
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2019-01-01, Year

Headquarters

Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
2
Total equity funding
$16.8M
Last funding
Debt Financing / $7M / 2024-05-01
Last equity funding
Series Unknown / $16.8M
Founders
1
Articles
1

Founders and investors

Founders

Sai Chavala